Company / AR per Share
Haemonetics AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.99
FY2025
5-year range
$2.48 / $4.09
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#62 of 141
Health Care
What the data says
At $3.99, Haemonetics's ar per share ranks #62 of 141 in the Health Care sector. AR per Share has fluctuated over the past 10 years, ranging from $2.48 in FY2021 to $4.09 in FY2024.
Based on SEC 10-K filings.
3.99 in FY2025 with a 5-year CAGR of +4.4%.
Improved from $3.49 to $3.99 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +4.4%
- 10-Year CAGR
- -
Sector benchmark
#62 of 141 in Health CareTop 44% of 141This company $3.99 Sector average $11.78
▼
-66.1% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 2.5% year-over-year.
- Ranks #62 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2024.
- Lowest ar per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.99 | -2.5% |
| FY2024 | $4.09 | +17.5% |
| FY2023 | $3.49 | +12.5% |
| FY2022 | $3.10 | +24.8% |
| FY2021 | $2.48 | -22.9% |
| FY2020 | $3.22 | -9.8% |
| FY2019 | $3.57 | +23.4% |
| FY2018 | $2.89 | -3.5% |
| FY2017 | $3.00 | -1.4% |
| FY2016 | $3.04 | +8.5% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026